Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperoxia Effects on Pulmonary Inflammation in Human In Vivo Model
NCT05414370Recruiting
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Dec 2022
- Primary completion
- Dec 2024
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxygen in acute lung injury (ALI) (2 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Bronchoalveolar lavage Interleukin-8 concentration. Started Dec 2022; status: recruiting.
02
Drugs
oxygen
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT05414370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05414370.